MTT #89: Trump’s second term, weight-loss drugs & the rise of ‘walking pneumonia’

Nov 19, 2024

The discussion delves into the potential healthcare ramifications of a second Trump presidency, including stricter Medicaid work requirements and changes to the Affordable Care Act. Weight-loss chatter centers on GLP-1 drugs, evaluating their effectiveness against bariatric surgery. There's also a concerning rise in walking pneumonia among children. Ethical issues surrounding Alzheimer's drug trials are raised, alongside insights into the dangers of prolonged sitting and the unexpected benefits of new IVF advancements.

Ask episode

Chapters

Books

Transcript

Episode notes

Intro

00:00 • 3min

Healthcare Access and Future Challenges

03:14 • 22min

Understanding Walking Pneumonia and Its Impact on Children

25:12 • 2min

Shifts in Weight Loss Treatments and Controversies in Alzheimer's Drug Approvals

27:03 • 5min

The Healthcare Dilemma: High Costs Amid Health

31:54 • 3min

In this episode of Medicine: The Truth, co-hosts Dr. Robert Pearl and Jeremy Corr tackle a wide array of medical issues, from the potential healthcare impact of a second Trump presidency to the latest trends in obesity treatments and respiratory infections.

With a historical election in the rearview mirror, the hosts dive into what a second Trump term could mean for Medicare, Medicaid, the Affordable Care Act and rural health. Among the key predictions: stricter work requirements for Medicaid, potential elimination of ACA subsidies and a likely push toward healthcare block grants for states.

The conversation also spotlights GLP-1 drugs, hailed as breakthroughs in weight-loss treatment. Dr. Pearl explains the pros and cons of these medications compared to bariatric surgery and the shifting dynamics they’ve introduced into obesity care.

Here’s a snapshot of just some of the topics covered on this episode of Medicine: The Truth:

The implications of Trump’s second term
GLP-1 drugs vs. bariatric surgery
Rising prevalence of walking pneumonia
Ethics of Alzheimer’s drug trials
Why sitting too long can harm you—and why standing might not be the solution
An unexpected outcome with advancements in IVF
Artificial intelligence in diagnosis

Join Dr. Robert Pearl and Jeremy Corr as they unpack these complex healthcare issues and shed light on the path ahead for American medicine.

* * *

Dr. Robert Pearl is the author of the new book “ChatGPT, MD: How AI-Empowered Patients & Doctors Can Take Back Control of American Medicine“ about the impact of AI on the future of medicine. All profits from the book go to Doctors Without Borders.

Fixing Healthcare is a co-production of Dr. Robert Pearl and Jeremy Corr. Subscribe to the show via Apple, Spotify, Stitcher or wherever you find podcasts. Join the conversation or suggest a guest by following the show on Twitter and LinkedIn.

The post MTT #89: Trump’s second term, weight-loss drugs & the rise of ‘walking pneumonia’ appeared first on Fixing Healthcare.